# A Trial to Assess the Safety, Tolerability, and Pharmacokinetics of the Anti-Orthopoxvirus Compound Tecovirimat

> **NCT02474589** · PHASE3 · COMPLETED · sponsor: **SIGA Technologies** · enrollment: 449 (actual)

## Conditions studied

- Smallpox

## Interventions

- **DRUG:** tecovirimat
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02474589
- **Lead sponsor:** SIGA Technologies
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06-19
- **Primary completion:** 2016-08-24
- **Final completion:** 2016-08-24
- **Target enrollment:** 449 (ACTUAL)
- **Last updated:** 2017-11-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02474589

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02474589, "A Trial to Assess the Safety, Tolerability, and Pharmacokinetics of the Anti-Orthopoxvirus Compound Tecovirimat". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02474589. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*